NCT05772975

Brief Summary

This clinical trial aims to compare the effect of platelet concentrates E-PRF and H-PRF on soft and hard tissue healing in healthy individuals after lower third molar surgery. The main questions it aims to answer are: Do E-PRF and H-PRF reduce complications after third molar surgery? Do E-PRF and H-PRF improve soft tissue healing after third molar surgery? Do E-PRF and H-PRF improve hard tissue healing after third molar surgery? Participants will be divided into 2 study groups and one control group. Third molar surgery will be performed according to standard protocol. In study groups, dentoalveolar defects will be filled with E-PRF and H-PRF which are products of centrifugation of the patient's blood without additives. Soft tissue and hard tissue healing will be compared between the groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started May 2021

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 21, 2021

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

February 15, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 17, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2024

Completed
Last Updated

August 9, 2024

Status Verified

August 1, 2024

Enrollment Period

2.7 years

First QC Date

February 15, 2023

Last Update Submit

August 8, 2024

Conditions

Keywords

Molar, ThirdPRFPlatelet-Rich Fibrin

Outcome Measures

Primary Outcomes (4)

  • The impact of E-PRF vs H-PRF vs Control on soft tissue healing

    Soft tissue healing evaluation will be done by modified Landry, Turnbull and Howley healing index. For each post-extraction site, the following parameters will be evaluated by dichotomic scale (0/1): tissue color, response to palpation, presence of granulation tissue, epithelialization of incision margins and suppuration.

    3 days

  • The impact of E-PRF vs H-PRF vs Control on soft tissue healing

    Soft tissue healing evaluation will be done by modified Landry, Turnbull and Howley healing index. For each post-extraction site, the following parameters will be evaluated by dichotomic scale (0/1): tissue color, response to palpation, presence of granulation tissue, epithelialization of incision margins and suppuration.

    7 days

  • The impact of E-PRF vs H-PRF vs Control on bone regeneration

    Bone healing will be evaluated by comparing digital OPGs i.e. radiographic bone densitiy profiles in extraction sockets will be compared.

    1 month

  • The impact of E-PRF vs H-PRF vs Control on bone regeneration

    Bone healing will be evaluated by comparing digital OPGs i.e. radiographic bone densitiy profiles in extraction sockets will be compared.

    3 months

Secondary Outcomes (7)

  • The impact of E-PRF vs H-PRF vs Control on periodontal pocket depth

    1 month

  • The impact of E-PRF vs H-PRF vs Control on periodontal pocket depth

    3 months

  • The impact of E-PRF vs H-PRF vs Control on postoperative trismus

    3 days

  • The impact of E-PRF vs H-PRF vs Control on postoperative trismus

    7 days

  • The impact of E-PRF vs H-PRF vs Control on postoperative swelling

    3 days

  • +2 more secondary outcomes

Study Arms (3)

E-PRF

EXPERIMENTAL

After the impacted mandibular third molar has been surgically removed E-PRF is placed in the dentoalveolar defect and the wound is primarily closed.

Biological: E-PRF

H-PRF

EXPERIMENTAL

After the impacted mandibular third molar has been surgically removed H-PRF is placed in the dentoalveolar defect PRF made with horizontal centrifuge and the wound is primarily closed.

Biological: H-PRF (Horizontal-platelet rich fibrin)

CONTROL

NO INTERVENTION

After the impacted mandibular third molar has been surgically removed, the wound is primarily closed.

Interventions

Platelet-rich fibrin is an autologous biomaterial originating from human blood following centrifugation without additives that contains supraphysiological doses of growth factors. it serves as a biological healing matrix by supporting cell migration and cytokine release. H-PRF is obtained by horizontal centrifugation using (Bio-PRF) centrifuge on 700 g force for 8 minutes. This way the cells separate much more efficiently throughout the entire membrane/clot.

H-PRF
E-PRFBIOLOGICAL

Platelet-rich fibrin is an autologous biomaterial originating from human blood following centrifugation without additives that contains supraphysiological doses of growth factors. In order to extend its resorption period heating method is used. After centrifugation of blood using (Bio-PRF) centrifuge on 700 g force for 8 minutes top layer is heated for 10 minutes at 75°C in BIO-Heat device. When cooled it is mixed with cell rich buffy coat. This way PRF with extended life is obtained.

E-PRF

Eligibility Criteria

Age16 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Orthodontic indication for impacted mandibular third molar surgery
  • Physical status I according to the guidelines of the American Society of Anesthesiologists (ASA)

You may not qualify if:

  • Presence of systemic disease
  • Presence of a condition that affects fibrin clot formation
  • History of radiation therapy or chemotherapy
  • Allergy to penicillin
  • Oral contraceptive usage
  • Smoking habit
  • Status of pregnancy or lactation
  • Presence of any acute local infection
  • Missing the adjacent second molar or indicated for extraction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry with Dental Clinical Center

Sarajevo, Federation of Bosnia and Herzegovina, 71000, Bosnia and Herzegovina

Location

Study Officials

  • Amila Haskic

    University of Sarajevo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 15, 2023

First Posted

March 17, 2023

Study Start

May 21, 2021

Primary Completion

January 30, 2024

Study Completion

January 30, 2024

Last Updated

August 9, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations